Hyperkalemia


Hyperkalemia Doubles Odds of ICU Stay Among Patients With Renal Failure With Complications at Large Tennessee Hospitals

No Image

By: James Pitt  May. 16, 2018

Hyperkalemia, an excess of blood potassium, is an electrolyte imbalance that is especially common in patients with heart failure or chronic kidney disease. Up to 6.35% of patients with HF or CKD have hyperkalemia. Dexur has previously reported on hyperkalemia and heart failure in Florida.

Read more

Data from Three New York Hospitals Show Hyperkalemia-Related Readmission Rates are Higher for Diabetic Patients

No Image

By: James Pitt  May. 01, 2018

A Dexur analysis of CMS Medicare claims data at three New York hospitals shows that patients diabetes are 1.6 to 5 times more likely to be readmitted with hyperkalemia than the average inpatient. The analysis looked at data between Jan 2013 to Dec 2016 for Montefiore Medical Center, Mt. Sinai & Strong Memorial for patients hospitalized with diabetes hospitalized for diabetes (DRGs 637, 638, and 639) and compared the readmissions across all inpatients. The higher odds of readmissions for these three hospitals were consistent with state & national trends.

Read more

Veltassa Could Show Potential in Heart Failure Patients Readmitted with Hyperkalemia

No Image

By: James Pitt  Apr. 18, 2018

Veltassa (patiromer) is a medication introduced in 2015 that binds potassium in the GI tract in order to lower high blood potassium levels, a condition known as hyperkalemia. Hyperkalemia is often comorbid with chronic conditions, including cardiovascular disease. One reason for this comorbidity may be the use of renin-angiotensin-aldosterone system (RAAS) inhibitors, which are very common in heart failure treatments.

Read more